Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...
Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback